In the chronic stage of TLE, excessive protein degradation is the primary reason for the loss of total EAAT2 levels; therefore, ceftriaxone has no significant inhibitory effect on chronic spontaneous seizures in epilepsy model mice (12). The gene discussed is SLC1A2; the disease is epilepsy.